ArcelorMittal's aggressive share buybacks and robust balance sheet provide a strong valuation floor, but structurally low ROIC, extreme capital intensity for European decarbonization, and peak historical multiples choke off any realistic near-term upside.
CRH's unmatched scale and recent $8.5B Arcosa acquisition deeply entrench its U.S. infrastructure monopoly, offering a compelling valuation discount relative to domestic peers alongside aggressive shareholder returns and consistent margin expansion.
Corteva possesses a dominant biotechnology moat shifting into highly lucrative royalty-positive economics, but severe near-term restructuring costs and an elevated valuation multiple mandate a 'Hold' until the complex corporate separation yields tangible value.
FCX is the ultimate vehicle to ride the structural AI and electrification copper super-cycle, provided investors can stomach the extreme geotechnical and geopolitical concentration risk embedded entirely within the Grasberg underground mine.